Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

444 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug-eluting stents for off-label indications in real clinical world: evidence based or 'intuition' based clinical practice?
Ribera A, Ferreira-González I, Del Blanco BG, Marsal JR, Cascant P, Martí G, Cequier AR, Gómez-Hospital JA, Fernandez-Nofrerías E, Carrillo X, López-Pérez MC, Navarro J, Raso R, García-Dorado D, Permanyer-Miralda G; ACDC study investigators. Ribera A, et al. Int J Cardiol. 2013 Mar 20;164(1):116-22. doi: 10.1016/j.ijcard.2011.06.096. Epub 2011 Jul 13. Int J Cardiol. 2013. PMID: 21741713
Prognostic value of an abnormal ankle-brachial index in patients receiving drug-eluting stents.
Ribera A, Ferreira-González I, Marsal JR, Cascant P, Permanyer-Miralda G, Abdul-Jawad O, Iñigo-Garcia LA, Guarinos-Oltra J, Cequier A, Goicolea-Güemez L, García-Del-Blanco B, Martí G, García-Dorado D. Ribera A, et al. Am J Cardiol. 2011 Nov 1;108(9):1225-31. doi: 10.1016/j.amjcard.2011.06.036. Epub 2011 Aug 25. Am J Cardiol. 2011. PMID: 21872197
Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year.
Ferreira-González I, Marsal JR, Ribera A, Permanyer-Miralda G, García-Del Blanco B, Martí G, Cascant P, Masotti-Centol M, Carrillo X, Mauri J, Batalla N, Larrousse E, Martín E, Serra A, Rumoroso JR, Ruiz-Salmerón R, de la Torre JM, Cequier A, Gómez-Hospital JA, Alfonso F, Martín-Yuste V, Sabatè M, García-Dorado D. Ferreira-González I, et al. J Am Coll Cardiol. 2012 Oct 9;60(15):1333-9. doi: 10.1016/j.jacc.2012.04.057. Epub 2012 Sep 19. J Am Coll Cardiol. 2012. PMID: 22999716 Free article.
Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation.
Ferreira-González I, Marsal JR, Ribera A, Permanyer-Miralda G, García-Del Blanco B, Martí G, Cascant P, Martín-Yuste V, Brugaletta S, Sabaté M, Alfonso F, Capote ML, De La Torre JM, Ruíz-Lera M, Sanmiguel D, Cárdenas M, Pujol B, Baz JA, Iñiguez A, Trillo R, González-Béjar O, Casanova J, Sánchez-Gila J, García-Dorado D. Ferreira-González I, et al. Circulation. 2010 Sep 7;122(10):1017-25. doi: 10.1161/CIRCULATIONAHA.110.938290. Epub 2010 Aug 23. Circulation. 2010. PMID: 20733100 Clinical Trial.
Prevalence of calcific aortic valve disease in the elderly and associated risk factors: a population-based study in a Mediterranean area.
Ferreira-González I, Pinar-Sopena J, Ribera A, Marsal JR, Cascant P, González-Alujas T, Evangelista A, Brotons C, Moral I, Permanyer-Miralda G, García-Dorado D, Tornos P. Ferreira-González I, et al. Eur J Prev Cardiol. 2013 Dec;20(6):1022-30. doi: 10.1177/2047487312451238. Epub 2012 Jun 7. Eur J Prev Cardiol. 2013. PMID: 22679252
"Pulmonary valve replacement diminishes the presence of restrictive physiology and reduces atrial volumes": a prospective study in Tetralogy of Fallot patients.
Pijuan-Domenech A, Pineda V, Castro MA, Sureda-Barbosa C, Ribera A, Cruz LM, Ferreira-Gonzalez I, Dos-Subirà L, Subirana-Domènech T, Garcia-Dorado D, Casaldàliga-Ferrer J. Pijuan-Domenech A, et al. Int J Cardiol. 2014 Nov 15;177(1):261-5. doi: 10.1016/j.ijcard.2014.09.009. Epub 2014 Sep 28. Int J Cardiol. 2014. PMID: 25499390
Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants.
Ribera A, Slof J, Andrea R, Falces C, Gutiérrez E, Del Valle-Fernández R, Morís-de la Tassa C, Mota P, Oteo JF, Cascant P, Altisent OA, Sureda C, Serra V, García-Del Blanco B, Tornos P, Garcia-Dorado D, Ferreira-González I. Ribera A, et al. Int J Cardiol. 2015 Mar 1;182:321-8. doi: 10.1016/j.ijcard.2014.12.109. Epub 2014 Dec 27. Int J Cardiol. 2015. PMID: 25585368
444 results